{
    "clinical_study": {
        "@rank": "80533", 
        "arm_group": [
            {
                "arm_group_label": "High Risk Depression", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Low Risk Depression", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Healthy Control", 
                "arm_group_type": "No Intervention"
            }, 
            {
                "arm_group_label": "Bipolar", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to find out what parts of the brain have increased or decreased\n      activity and connectivity in individuals who have bipolar disorder, major depression, or no\n      history of mood disorder. Another purpose of this study is to use MRI images to determine\n      which young adults with major depression may be at greater risk for developing mild or more\n      severe symptoms of mania which suggests a diagnosis of bipolar disorder."
        }, 
        "brief_title": "Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI", 
        "condition": [
            "Bipolar Disorder", 
            "Major Depression"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bipolar Disorder", 
                "Depression", 
                "Depressive Disorder", 
                "Depressive Disorder, Major"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "INCLUSION CRITERIA FOR BIPOLAR DEPRESSED PATIENTS:\n\n          1. Ages 16 - 30 years (inclusive) and able to give voluntary informed consent (parents\n             must also sign consent for subjects under 18)\n\n          2. Satisfy criteria for Diagnostic and Statistical Manual 4th edition (DSM-IV-TR) for\n             Bipolar I or II disorder\n\n          3. Satisfy criteria for DSM-IV depressive episode-current\n\n          4. 17-item Hamilton Depression Rating Scale > 18 but < 25;\n\n          5. Young Mania Rating Scale score < 10\n\n          6. Satisfy criteria to undergo an MRI scan based on MRI screening questionnaire.\n\n          7. Able to be managed as outpatients during the study as ascertained by the following -\n             i. Clinical Global Severity Scale < 5 i.e. moderately ill; ii. No significant\n             suicidal or homicidal ideation or grossly disabled.\n\n        INCLUSION CRITERIA FOR ALL UNIPOLAR DEPRESSED PATIENTS:\n\n          1. Ages 16 - 30 years and able to give voluntary informed consent (Parental consent must\n             also be obtained for those under 18 years old).\n\n          2. Satisfy criteria for DSM-IV-TR Major Depressive Episode using  a Structured Interview\n\n          3. Never met criteria for mania or hypomania\n\n          4. 17-item Hamilton Depression Rating Scale score (HDRS) > 18 and < 25.\n\n          5. Young Mania Rating Scale (YMRS) score < 10\n\n          6. Satisfy safety criteria to undergo an MRI scan\n\n          7. Able to be managed as outpatients during the study as ascertained by the following -\n             i. Clinical Global Severity Scale < 5 i.e. moderately ill; ii. No significant\n             suicidal or homicidal ideation or grossly disabled\n\n        ADDITIONAL INCLUSION CRITERIA FOR HIGH RISK UD (HRUD) PATIENTS BESIDE THE INCLUSION\n        CRITERIA FOR UD:\n\n        At least one of the following:\n\n          1. Family history of bipolar disorder in at least one first degree relative\n\n          2. History of any sub-threshold hypomania symptoms\n\n          3. History of mood episode related psychotic symptoms\n\n        ADDITIONAL INCLUSION CRITERIA FOR LOW RISK UD (HRUD) PATIENTS BESIDE THE INCLUSION\n        CRITERIA FOR UD:\n\n          1. No family history of BD in a first or a second degree relative\n\n          2. No past history of any sub-threshold hypomania symptoms\n\n          3. No history of psychotic symptoms\n\n        EXCLUSION CRITERIA FOR DEPRESSION AND BIPOLAR SUBJECTS:\n\n          1. Meeting DSM-IV criteria for schizophrenia, schizophreniform disorder, schizoaffective\n             disorder, mental retardation, pervasive developmental disorder.\n\n          2. History of receiving electroconvulsive therapy in the past 1 year\n\n          3. Use of neuroleptics, mood stabilizers or benzodiazepines in the past 2 weeks.\n\n          4. Use of antidepressants in the past 2 weeks.\n\n          5. If on fluoxetine in the past, then should not have been on this medication for 5\n             weeks.\n\n          6. Acutely suicidal or homicidal or requiring inpatient treatment.\n\n          7. Meeting DSM-IV criteria for other substance/alcohol dependence within the past 6\n             months or abuse in the past 3 months, excluding caffeine or nicotine.  The criteria\n             will be evaluated by interview and urinary toxicology screening. The use of caffeine\n             or nicotine will be recorded.\n\n          8. Use of alcohol in the past 1 week before the MRI scan.\n\n          9. No serious acute or chronic medical or neurological illness, including previously\n             known HIV positive status (due to possible CNS involvement) as assessed by history,\n             physical examination and laboratory examination including EKG, CBC and blood\n             chemistry.\n\n         10. Current pregnancy or breast feeding.\n\n         11. Metallic implants or other contraindication to MRI.\n\n        INCLUSION CRITERIA FOR HEALTHY CONTROLS: Healthy subjects matched for age, gender and\n        ethnicity will be included\n\n          1. Ages 16 - 30 years (inclusive) and able to give voluntary informed consent (Parental\n             consent must also be obtained for those under 18 years old)\n\n          2. No current or past history of psychiatric illness or substance abuse or dependence.\n\n          3. No current or past history of psychiatric illness or substance abuse or dependence in\n             a first degree relative.\n\n        EXCLUSION CRITERIA FOR HEALTHY CONTROLS:\n\n          1. Pregnant or breast feeding.\n\n          2. Metallic implants or other contraindication to MRI.\n\n          3. Significant family history of psychiatric or neurological illness.\n\n          4. Currently taking any prescription or centrally acting medications.\n\n          5. Serious acute or chronic medical or neurological illness as assessed by history,\n             physical examination and laboratory examination including CBC and blood chemistry.\n\n          6. Use of alcohol in the past 1 week and not being able to avoid alcohol use during the\n             course of the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01811147", 
            "org_study_id": "1106005847"
        }, 
        "intervention": {
            "arm_group_label": [
                "High Risk Depression", 
                "Low Risk Depression"
            ], 
            "description": "Subjects with depression will be treated with a Selective Serotonin Reuptake Inhibitor (SSRI) for 24 months", 
            "intervention_name": "Selective Serotonin Reuptake Inhibitor (SSRI)", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Serotonin", 
                "Serotonin Uptake Inhibitors"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Bipolar", 
            "Depression", 
            "Mania", 
            "Hypomania", 
            "fMRI", 
            "antidepressant"
        ], 
        "lastchanged_date": "April 16, 2013", 
        "location": {
            "contact": {
                "email": "ananda@ccf.org", 
                "last_name": "Amit Anand, MD", 
                "phone": "216-636-2840"
            }, 
            "contact_backup": {
                "email": "wintera@ccf.org", 
                "last_name": "Adrienna Winters, BS", 
                "phone": "216-445-2378"
            }, 
            "facility": {
                "address": {
                    "city": "Cleveland", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "44195"
                }, 
                "name": "Cleveland Clinic Foundation Center for Behavioral Health"
            }, 
            "investigator": {
                "last_name": "Amit Anand, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI", 
        "overall_contact": {
            "email": "abdfrenc@iupui.edu", 
            "last_name": "Abi D Gunn, MS", 
            "phone": "317-944-0318"
        }, 
        "overall_official": {
            "affiliation": "The Cleveland Clinic", 
            "last_name": "Amit Anand, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Federal Government", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Hamilton depression rating scale", 
            "safety_issue": "No", 
            "time_frame": "24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01811147"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Young Mania Rating Scale", 
            "safety_issue": "No", 
            "time_frame": "24 months"
        }, 
        "source": "Indiana University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Indiana University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}